Related Experiment Video
Updated: Aug 7, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
[Devices for the safe performance of self-injection of interferon therapy for chronic hepatitis C]
Tomoko Kurihara1, Rintaro Mikata, Osamu Yokosuka
1Department of Medicine and Clinical Oncology, Graduate School of Medicine Chiba University.
Abstract:
Long-term interferon therapy is an alternative therapy for patients with chronic hepatitis C who can not tolerate to the combination of pegylated interferon and ribavirin. In 2005, self-injection of interferon for chronic hepatitis C was covered by public health insurance in Japan making the long-term interferon therapy easier to perform. For the safe performance of self-injection, education about knowledge on various adverse effects of interferon, training for actual performance of self-injection, and close contact between the patients and doctors are indispensable. In this review, we briefly summarized why self-injection is needed and how the training for safe self-injection of interferon should be performed.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
